Related Experiment Video

Updated: May 6, 2026

Technique of Minimally Invasive Transverse Aortic Constriction in Mice for Induction of Left Ventricular Hypertrophy
08:34

Technique of Minimally Invasive Transverse Aortic Constriction in Mice for Induction of Left Ventricular Hypertrophy

Published on: September 25, 2017

24.2K

Reversal of cardiac hypertrophy by medical treatment

R C Tarazi, F M Fouad

    Annual Review of Medicine
    |January 1, 1985
    PubMed

    Insights

    Effective blood pressure control can reverse left ventricular hypertrophy in hypertensive patients. This regression depends on stable blood pressure and other factors beyond just pressure reduction, ensuring normal heart function.

    Area of Science:

    • Cardiology
    • Hypertension Research
    • Pharmacology

    Background:

    • Left ventricular hypertrophy (LVH) is a common complication of hypertension.
    • Reversal of LVH has been observed with antihypertensive therapy.
    • The precise mechanisms and influencing factors of LVH regression require further elucidation.

    Purpose of the Study:

    • To investigate the factors influencing the regression of left ventricular hypertrophy in hypertensive patients.
    • To determine if blood pressure reduction alone is sufficient for LVH reversal.
    • To assess the impact of stable blood pressure control and other modulators on LVH regression.

    Main Methods:

    • Analysis of hypertensive patients undergoing antihypertensive drug treatment.
    • Evaluation of blood pressure control stability.
    • Assessment of cardioadrenergic stimulation levels.
    • Consideration of genetic background and age-related variations.

    Main Results:

    • Reversal of LVH is achievable through effective blood pressure control.
    • LVH regression is influenced by factors beyond the magnitude of blood pressure reduction, including control stability and cardioadrenergic activity.
    • Optimal regression occurs when arterial pressure reduction is sustained without reflex cardiac stimulation.
    • Left ventricular performance at rest remained normal post-regression, unaffected by reduced cardiac mass.

    Conclusions:

    • Effective blood pressure management is key to reversing left ventricular hypertrophy in hypertensive individuals.
    • Sustained, stable blood pressure reduction without compensatory cardiac stimulation promotes LVH regression.
    • Individual factors such as genetics and age may modulate the response to antihypertensive therapy for LVH reversal.

    More Related Videos

    Studying Left Ventricular Reverse Remodeling by Aortic Debanding in Rodents07:26

    Studying Left Ventricular Reverse Remodeling by Aortic Debanding in Rodents

    Published on: July 14, 2021

    4.6K
    A Model of Reverse Vascular Remodeling in Pulmonary Hypertension Due to Left Heart Disease by Aortic Debanding in Rats07:41

    A Model of Reverse Vascular Remodeling in Pulmonary Hypertension Due to Left Heart Disease by Aortic Debanding in Rats

    Published on: March 1, 2022

    2.5K

    Related Concept Videos

    Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

    Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

    The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
    2.1K
    Aortic Regurgitation III: Medical Management01:25

    Aortic Regurgitation III: Medical Management

    Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
    598
    Myocarditis III: Medical Management01:14

    Myocarditis III: Medical Management

    Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
    344
    Heart Failure V: Medical Management01:30

    Heart Failure V: Medical Management

    Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
    641
    Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

    Cardiomyopathy III: Hypertrophic Cardiomyopathy

    Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
    810
    Cardiomyopathy V: Interprofessional Care01:29

    Cardiomyopathy V: Interprofessional Care

    Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
    761